The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

First patient dosed in UPSTREAM SjD, a global Phase 3 clinical trial assessing telitacicept in primary Sjögren’s disease $75 million private placement strengthens balance sheet and supports ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

SAN FRANCISCO--(BUSINESS WIRE)--Vor Systems, an AI-enabled transaction platform built for complex renewable energy deals, today announced it has raised $3 million in pre-seed funding led by Gigascale ...

Vor Systems announced it secured $3 million in pre-seed financing to support the development of its AI-enabled transaction platform built for complex renewable energy deals. The funding round was led ...

In December, Howard Marks published an investment memo titled, “Is it a bubble?” that expressed some of his skepticism and reservations about artificial intelligence and the stock-market boom it had ...

Self-serve platform removes traditional barriers of cost, implementation, and training that have kept powerful AI tools out of reach for most legal practices NEW YORK, Jan. 27, 2026 /PRNewswire/ -- ...

Northwestern Air Lease flight PLR732T, a BAe Jetstream 31, was conducting training at the Fort Smith airport (YSM), NT with two flight crew on board. After completing a VOR approach to runway 12, the ...

JPMorgan initiated coverage on Vor Biopharma (NASDAQ:VOR) with an Overweight rating and $43 price target, representing over 400% upside from current levels The investment bank views telitacicept, a ...

Vor Biopharma Inc. (VOR) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...